Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (56)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Wilson, V. S.
Right arrow Articles by Gray, L. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wilson, V. S.
Right arrow Articles by Gray, L. E., Jr.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Toxicological Sciences 66, 69-81 (2002)
Copyright © 2002 by the Society of Toxicology


ENDOCRINE TOXICOLOGY

A Novel Cell Line, MDA-kb2, That Stably Expresses an Androgen- and Glucocorticoid-Responsive Reporter for the Detection of Hormone Receptor Agonists and Antagonists

Vickie S. Wilson,1, Kathy Bobseine, Christy R. Lambright and L. E. Gray, Jr.

U.S. Environmental Protection Agency, Office of Research and Development, National Health and Environmental Effects Research Laboratory, Reproductive Toxicology Division, MD-72, Research Triangle Park, North Carolina 27711

The U.S. Environmental Protection Agency has proposed that in vitro assays for estrogen receptor (ER)- and androgen receptor (AR)-mediated actions be included in a Tier-I screening battery to detect hormonally active chemicals. Herein we describe the development of a novel stable cell line, MDA-kb2, for screening of androgen agonist and antagonists and to characterize its specificity and sensitivity to endocrine-disrupting chemicals. The breast cancer cell line, MDA-MB-453, was stably transformed with the MMTV.luciferase.neo reporter gene construct. Since both GR and AR are present in the MDA-MB-453 cells, and both receptors can act through the MMTV promoter, compounds that act through either AR or GR activate the MMTV luciferase reporter. As expected, AR agonists such as dihydrotestosterone (DHT), and GR agonists such as dexamethasone (DEX), corticosterone, and aldosterone induce luciferase expression at appropriate concentrations. DHT consistently produced 3–9-fold induction at concentrations from 0.1 to 10 nM. At 1 to 1000 nM, DEX induced luciferase activity 1.3–19.5-fold. To distinguish AR- from GR-mediated ligands, chemicals were assayed concurrently with the antiandrogen, hydroxyflutamide (OHF), which blocks AR- but not GR-mediated responses. In addition, known AR antagonists, including hydroxyflutamide, vinclozolin, vinclozolin metabolites M1 and M2, p,p`-DDE, and linuron inhibited DHT-induced luciferase gene expression at appropriate concentrations in this system. We have found that these cells are relatively easy to culture and maintain. Responsiveness was monitored over time and was stable for more than 80 passages. Some advantages of this assay are that it is relatively rapid (2 days), eliminates the need for transfection, can be conducted in a 96-well plate format, and produces consistent reproducible results. In summary, we have developed a cell line that can be used to screen chemicals, not just for AR- but for GR-mediated activities as well.

Key Words: stable cell line; androgen receptor; glucocorticoid receptor; endocrine screening; antiandrogen; vinclozolin; p`,p-DDE; linuron, procymidone; HPTE.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Protein Eng Des SelHome page
A. Tasdemir, F. Khan, T. A. Jowitt, L. Iuzzolino, S. Lohmer, S. Corazza, and T. J. Schmidt
Engineering of a monomeric fluorescent protein AsGFP499 and its applications in a dual translocation and transcription assay
Protein Eng. Des. Sel., August 1, 2008; (2008) gzn040v1.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
P. Roy, M. Alevizaki, and I. Huhtaniemi
In vitro bioassays for androgens and their diagnostic applications
Hum. Reprod. Update, January 1, 2008; 14(1): 73 - 82.
[Abstract] [Full Text] [PDF]


Home page
Genome ResHome page
J. H. Dennis, H.-Y. Fan, S. M. Reynolds, G. Yuan, J. C. Meldrim, D. J. Richter, D. G. Peterson, O. J. Rando, W. S. Noble, and R. E. Kingston
Independent and complementary methods for large-scale structural analysis of mammalian chromatin
Genome Res., June 1, 2007; 17(6): 928 - 939.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
D. V. Henley, N. Lipson, K. S. Korach, and C. A. Bloch
Prepubertal Gynecomastia Linked to Lavender and Tea Tree Oils
N. Engl. J. Med., February 1, 2007; 356(5): 479 - 485.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. Chen, M. R. Sowers, F. M. Moran, D. S. McConnell, N. A. Gee, G. A. Greendale, C. Whitehead, S. E. Kasim-Karakas, and B. L. Lasley
Circulating Bioactive Androgens in Midlife Women
J. Clin. Endocrinol. Metab., November 1, 2006; 91(11): 4387 - 4394.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
E. Sonneveld, J. A. C. Riteco, H. J. Jansen, B. Pieterse, A. Brouwer, W. G. Schoonen, and B. van der Burg
Comparison of In Vitro and In Vivo Screening Models for Androgenic and Estrogenic Activities
Toxicol. Sci., January 1, 2006; 89(1): 173 - 187.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
H.-J. Kim, Y. I. Park, and M.-S. Dong
Effects of 2,4-D and DCP on the DHT-Induced Androgenic Action in Human Prostate Cancer Cells
Toxicol. Sci., November 1, 2005; 88(1): 52 - 59.
[Abstract] [Full Text] [PDF]


Home page
J Biomol ScreenHome page
R. M. Katso, J. H. Parham, M. Caivano, W. C. Clay, J. P. Condreay, D. W. Gray, K. M. Lindley, S. J. Mason, J. Rieger, N. C. Wakes, et al.
Evaluation of Cell-Based Assays for Steroid Nuclear Receptors Delivered by Recombinant Baculoviruses
J Biomol Screen, October 1, 2005; 10(7): 715 - 724.
[Abstract] [PDF]


Home page
Biol. Reprod.Home page
N. C. Noriega, J. Ostby, C. Lambright, V. S. Wilson, and L. E. Gray Jr.
Late Gestational Exposure to the Fungicide Prochloraz Delays the Onset of Parturition and Causes Reproductive Malformations in Male but Not Female Rat Offspring
Biol Reprod, June 1, 2005; 72(6): 1324 - 1335.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
E. Sonneveld, H. J. Jansen, J. A. C. Riteco, A. Brouwer, and B. van der Burg
Development of Androgen- and Estrogen-Responsive Bioassays, Members of a Panel of Human Cell Line-Based Highly Selective Steroid-Responsive Bioassays
Toxicol. Sci., January 1, 2005; 83(1): 136 - 148.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
V. S. Wilson, K. Bobseine, and L. E. Gray Jr.
Development and Characterization of a Cell Line That Stably Expresses an Estrogen-Responsive Luciferase Reporter for the Detection of Estrogen Receptor Agonist and Antagonists
Toxicol. Sci., September 1, 2004; 81(1): 69 - 77.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
J. T. E. Lim, G. A. Piazza, R. Pamukcu, W. J. Thompson, and I. B. Weinstein
Exisulind and Related Compounds Inhibit Expression and Function of the Androgen Receptor in Human Prostate Cancer Cells
Clin. Cancer Res., October 15, 2003; 9(13): 4972 - 4982.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
R. Ma, B. Cotton, W. Lichtensteiger, and M. Schlumpf
UV Filters with Antagonistic Action at Androgen Receptors in the MDA-kb2 Cell Transcriptional-Activation Assay
Toxicol. Sci., July 1, 2003; 74(1): 43 - 50.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
V. S. Wilson, C. Lambright, J. Ostby, and L. E. Gray Jr.
In Vitro and in Vivo Effects of 17{beta}-Trenbolone: A Feedlot Effluent Contaminant
Toxicol. Sci., December 1, 2002; 70(2): 202 - 211.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
P. C. Hartig, K. L. Bobseine, B. H. Britt, M. C. Cardon, C. R. Lambright, V. S. Wilson, and L. E. Gray Jr.
Development of Two Androgen Receptor Assays Using Adenoviral Transduction of MMTV-Luc Reporter and/or hAR for Endocrine Screening
Toxicol. Sci., March 1, 2002; 66(1): 82 - 90.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.